Daily Sepsis Research Analysis
A network meta-analysis of 28 RCTs (n=8,770) indicates balanced crystalloids reduce mortality versus saline and hydroxyethyl starch in sepsis, while hyperoncotic albumin best mitigates AKI. A prospective validation study shows an AI-driven sepsis score (VC-SEPS) outperforms traditional scores and predicts sepsis ~68 minutes earlier. Bioinformatics across multiple transcriptomic cohorts proposes a BCL2–MAPK14–TXN diagnostic model and highlights TXN as an oxidative stress-related signature gene.
Summary
A network meta-analysis of 28 RCTs (n=8,770) indicates balanced crystalloids reduce mortality versus saline and hydroxyethyl starch in sepsis, while hyperoncotic albumin best mitigates AKI. A prospective validation study shows an AI-driven sepsis score (VC-SEPS) outperforms traditional scores and predicts sepsis ~68 minutes earlier. Bioinformatics across multiple transcriptomic cohorts proposes a BCL2–MAPK14–TXN diagnostic model and highlights TXN as an oxidative stress-related signature gene.
Research Themes
- Fluid resuscitation optimization in sepsis
- AI-driven early detection and risk stratification
- Oxidative stress biomarkers and systems biology
Selected Articles
1. Fluid resuscitation management in patients with sepsis and septic shock: a network meta-analysis.
Across 28 RCTs (n=8,770), balanced crystalloids reduced 90-day mortality versus saline and low–molecular-weight HES and lowered RRT need versus high–molecular-weight HES. SUCRA rankings consistently favored balanced crystalloids for mortality, RRT, and transfusion, while hyperoncotic albumin ranked best for AKI prevention.
Impact: Synthesizes the highest-level evidence to guide initial fluid choice in sepsis, showing mortality benefit and renal protection signals. Findings can inform immediate practice and future guideline updates.
Clinical Implications: Prioritize balanced crystalloids over saline and HES for initial resuscitation; avoid HES given inferior outcomes. Consider the role of hyperoncotic albumin where AKI risk is high, while confirming indications and dosing in specific populations.
Key Findings
- Balanced crystalloids reduced 90-day mortality versus saline (RR -0.89; 95% CrI 0.81–0.97) and L-HES (RR -0.84; 95% CrI 0.75–0.95).
- Balanced crystalloids lowered the need for renal replacement therapy compared with H-HES (RR -0.59; 95% CrI 0.30–0.99).
- SUCRA rankings: BC highest for 28- and 90-day mortality, RRT, and blood transfusion; hyperoncotic albumin highest for reducing AKI.
Methodological Strengths
- Comprehensive multi-database search through September 2024 with predefined criteria
- Risk of Bias 2 assessment and network meta-analysis with SUCRA ranking across 28 RCTs (n=8,770)
Limitations
- Potential heterogeneity in patient populations, dosing, and resuscitation protocols across trials
- Indirect comparisons inherent to network meta-analysis and possible publication bias
Future Directions: Head-to-head pragmatic trials comparing balanced crystalloids with saline in diverse settings; trials clarifying the role of hyperoncotic albumin in high-AKI-risk subgroups.
BACKGROUND: Fluid resuscitation is a cornerstone intervention for patients with sepsis. This network meta-analysis aimed to compare various fluid resuscitation strategies on complications, treatment responses, and outcomes in patients with sepsis or septic shock. METHODS: PubMed, Cochrane Central Register of Controlled Trials, Embase, and Web of Science were comprehensively searched for records available up to September 2024. Studies were screened and data were extracted based on preset inclusion and exclusion criteria. The quality of studies was evaluated via the Risk of Bias 2 tool. Data analyses were done in Stata18 MP and R 4.4.1. RESULTS: 28 randomized controlled trials were recruited, encompassing 8770 patients. Balanced crystalloids (BC) demonstrated superior efficacy over low molecular weight hydroxyethyl starch (L-HES) (RR -0.84; 95 % CrI [0.75, 0.95]) and saline (RR -0.89; 95 % CrI [0.81, 0.97]) in reducing 90-day mortality. In terms of complications, BC was linked with a reduced need for renal replacement therapy (RRT) (RR -0.59; 95 % CrI [0.3, 0.99]) compared to high molecular weight hydroxyethyl starch (H-HES). BC ranked highest in reducing 28-day mortality (SUCRA = 71.4 %), demand for RRT (SUCRA = 75.5 %), blood transfusion (BT) (SUCRA = 72.2 %), and 90-day mortality (SUCRA = 86.3 %). Hyperoncotic albumin (Hyper-Alb) was most effective in reducing the incidence of acute kidney injury (AKI) (SUCRA = 74.5 %). CONCLUSION: BC holds significant clinical potential for fluid resuscitation in patients with sepsis and septic shock. It outperforms both L-HES and saline in reducing mortality among these patients, while Hyper-Alb is most effective in mitigating renal injury.
2. Validation of an artificial intelligence-based algorithm for predictive performance and risk stratification of sepsis using real-world data from hospitalised patients: a prospective observational study.
In a prospective real-world cohort (n=6,455), the deep learning VC-SEPS score achieved AUROC 0.880, outperforming traditional scores and predicting sepsis on average 68 minutes earlier. Performance remained stable within 24 hours, supporting utility for early risk stratification and intervention.
Impact: Prospective validation with large sample size demonstrates robust, earlier detection than standard scores, addressing a critical window for timely sepsis care.
Clinical Implications: Integration into EHR as a clinical decision support tool could shorten time-to-recognition and antibiotics, potentially improving outcomes; requires workflow integration and monitoring of alert burden.
Key Findings
- Prospective cohort of 6,455 patients (325 sepsis) with AUROC 0.880 for VC-SEPS.
- VC-SEPS predicted sepsis a mean of 68.05 minutes earlier than an operational diagnosis time.
- Predictive performance remained consistent within the first 24 hours of admission and exceeded traditional scoring systems.
Methodological Strengths
- Prospective observational design with large real-world cohort
- Direct comparison with traditional scoring systems and time-to-detection analysis
Limitations
- Single-center study limits generalizability; external validation needed
- Operational definition of sepsis may introduce labeling bias; alert burden and clinician adoption not assessed
Future Directions: Multicenter external validation with impact analyses on time-to-antibiotics and outcomes; fairness, transportability, and calibration drift monitoring after deployment.
OBJECTIVE: The heterogeneous nature of sepsis renders determining its underlying causes difficult, which may delay diagnosis and intervention. VitalCare-SEPsis Score (VC-SEPS) is a deep learning-based algorithm that predicts sepsis and monitors patient conditions based on electronic medical record data. However, few studies have prospectively compared medical artificial intelligence software algorithms and traditional scoring systems to predict sepsis. This prospective observational study attempted to validate the predictive performance and risk stratification of VC-SEPS for early prediction of sepsis. METHODS: In this prospective observational study, we collected electronic medical record data from 6,797 patients hospitalised at Keimyung University Dongsan Hospital, Daegu, South Korea. The final version of the analysed set included 6,455 patients, 325 of whom were diagnosed with sepsis. RESULTS: The area under the receiver operating characteristic curve of VC-SEPS was 0.880, indicating its superiority over traditional scoring systems. The algorithm performance showed a consistent trend within 24 hours. On patients' initial admission, the VC-SEPS was associated with the risk of developing sepsis, and the score accurately predicted sepsis by an average of 68.05 min compared with diagnosis time by an operational definition of sepsis. DISCUSSION: VC-SEPS could assist medical staff with early diagnosis and intervention in clinical practice by providing a sepsis risk score. Prompt recognition assisting recognition can significantly help shorten the time between recognition and intervention in clinical decision-making processes. CONCLUSION: This study suggests that using a clinical decision support system can help improve hospital workflows as well as the quality of medical care.
3. Transcriptomic bioinformatics analysis proposes a novel BCL2-MAPK14-TXN oxidative stress diagnostic model of sepsis and identifies TXN as an oxidative stress-related signature gene in sepsis.
Cross-dataset bioinformatics identified BCL2, MAPK14, and TXN as oxidative stress–related hub genes and built a diagnostic nomogram that distinguished sepsis from controls across multiple cohorts. TXN correlated with broad immune cell infiltration and showed initial experimental support as an oxidative stress regulator in sepsis.
Impact: Proposes a mechanistically grounded diagnostic model and nominates TXN as a potentially actionable biomarker, integrating bulk and single-cell data with initial wet-lab validation.
Clinical Implications: If validated prospectively, the BCL2–MAPK14–TXN panel could support early diagnosis and risk stratification; TXN may inform oxidative stress–targeted interventions.
Key Findings
- Machine learning across GEO datasets identified BCL2, MAPK14, and TXN as oxidative stress–related hub genes.
- A diagnostic nomogram showed strong in silico performance distinguishing sepsis from controls across training, test, and validation cohorts.
- TXN correlated with multiple immune cell populations and showed initial experimental confirmation of its role in septic oxidative stress.
Methodological Strengths
- Multi-cohort design with training, test, and external validation using GEO datasets
- Integrated approaches: machine learning feature selection, CIBERSORT/ssGSEA immune infiltration, single-cell analysis, and experimental validation
Limitations
- Primarily in silico and retrospective; lacks prospective clinical validation and standardized thresholds
- Potential batch effects and heterogeneity across public datasets; limited in vivo mechanistic validation
Future Directions: Prospective, multicenter biomarker validation with predefined cutoffs; mechanistic studies of TXN in animal models and interventional trials targeting oxidative stress.
BACKGROUND: Oxidative stress was one of key factors driving the septic development by the uncontrolled accumulation of free radicals, thus oxidative stress-related biomarkers provide a novel diagnostic option. This study focused on screening oxidative stress-related genes and validating their diagnostic utility. METHODS: We obtained microarray datasets (GSE65682, GSE95233, GSE131761, and GSE33118) from the NCBI Gene Expression Omnibus (GEO) database and assigned them to the training, test, and validation cohorts. In the training cohort, differential expression genes (DEGs) were screened and intersected with oxidative stress-related genes for oxidative stress-related DEGs (OSDEGs). Machine learning algorithms were applied when selecting hub-OSDEGs, and examinations of their septic change and diagnostic value were replicated in test and validation cohorts. Immune infiltration analyses by CIBERSORT and ssGSEA were conducted, and the single-cell RNA sequencing dataset (GSE175453) was also analysed. Experimental validation proceeded to seek the reliability of bioinformatical results. RESULTS: BCL2, MAPK14, and TXN were determined by machine learning algorithms. One diagnostic nomogram was established and validated triply in silico, showing excellent diagnostic efficacy in distinguishing septic status from control status. TXN significantly correlated with the abundance of most immunocytes, and its role in septic oxidative stress was initially confirmed experimentally. CONCLUSIONS: One novel BCL2-MAPK14-TXN predictive model of sepsis was proposed, and the role of TXN in regulating oxidative stress in sepsis was initially explored. Further steps should be taken in promoting the application.